Strs Ohio lessened its position in shares of CorVel Co. (NASDAQ:CRVL – Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,900 shares of the business services provider’s stock after selling 500 shares during the period. Strs Ohio’s holdings in CorVel were worth $964,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in CRVL. Boston Trust Walden Corp lifted its position in shares of CorVel by 6.9% during the 3rd quarter. Boston Trust Walden Corp now owns 278,027 shares of the business services provider’s stock valued at $54,674,000 after buying an additional 17,954 shares during the last quarter. Raymond James & Associates raised its stake in shares of CorVel by 34.1% during the 3rd quarter. Raymond James & Associates now owns 59,060 shares of the business services provider’s stock valued at $11,614,000 after purchasing an additional 15,030 shares during the period. West Coast Financial LLC raised its stake in shares of CorVel by 98.9% during the 4th quarter. West Coast Financial LLC now owns 29,198 shares of the business services provider’s stock valued at $7,218,000 after purchasing an additional 14,515 shares during the period. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of CorVel by 0.6% during the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,965,355 shares of the business services provider’s stock valued at $386,487,000 after purchasing an additional 12,250 shares during the period. Finally, Stifel Financial Corp raised its stake in shares of CorVel by 36.3% during the 3rd quarter. Stifel Financial Corp now owns 23,982 shares of the business services provider’s stock valued at $4,716,000 after purchasing an additional 6,385 shares during the period. Hedge funds and other institutional investors own 51.36% of the company’s stock.
CorVel Stock Performance
NASDAQ:CRVL opened at $240.08 on Wednesday. CorVel Co. has a 52-week low of $187.92 and a 52-week high of $265.14. The firm has a market cap of $4.11 billion, a price-to-earnings ratio of 55.57 and a beta of 1.07. The business’s fifty day moving average is $244.88 and its 200 day moving average is $229.94.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, March 16th.
Read Our Latest Research Report on CRVL
Insiders Place Their Bets
In other CorVel news, VP Jennifer Yoss sold 1,500 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $239.41, for a total value of $359,115.00. Following the transaction, the vice president now directly owns 512 shares in the company, valued at approximately $122,577.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other CorVel news, VP Jennifer Yoss sold 1,500 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $239.41, for a total value of $359,115.00. Following the transaction, the vice president now directly owns 512 shares in the company, valued at approximately $122,577.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Steven J. Hamerslag sold 2,000 shares of the company’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $239.95, for a total value of $479,900.00. Following the completion of the transaction, the director now owns 114,389 shares in the company, valued at $27,447,640.55. The disclosure for this sale can be found here. Insiders have sold 16,043 shares of company stock worth $3,960,007 in the last ninety days. 48.71% of the stock is currently owned by insiders.
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Further Reading
- Five stocks we like better than CorVel
- CD Calculator: Certificate of Deposit Calculator
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.